Independence

We sell no peptides.
Our answers are for sale to no one.

In a market where most “guidance” comes from someone who profits when you buy a compound, our independence is the product. It is the one thing a telehealth platform or compound seller structurally cannot claim.

We sell no compounds

DoseCraft does not manufacture, stock, ship, or sell any peptide. We have no inventory to move and no margin tied to you starting a protocol. A platform that profits from compound sales has a reason to nudge you toward use — we structurally do not.

Our answers are for sale to no one

No vendor pays to be graded up a lane. No brand sponsors a verdict. Our evidence lanes are assigned by the strength of the data and cannot be bought, period. The grading you see is the grading we'd give if no one were watching.

No prescriptions, no conflicts

We don't run a telehealth arm, write prescriptions, or take a cut of a clinic visit. Platforms that sell the consult and the compound make more when you use more. That conflict isn't in our model — we make the same whether you run a protocol or don't.

How we actually make money

Independence only means something if it’s specific. Here is the whole picture, including the parts most companies bury.

Subscriptions and digital guides.

DoseCraft is funded by people paying for the software and for research-pack PDFs — not by anyone paying us to shape what the evidence says. You are the customer, not the product.

Affiliate links, disclosed and walled off from grading.

Some pages link to a third-party vendor we’ve vetted, and those links can earn a commission. We disclose them wherever they appear, and they are deliberately walled off from our evidence grading: a vendor cannot pay to move a compound into a stronger lane, and no commission changes how a claim is scored. We sell no compound ourselves and hold no inventory.

No pay-to-rank verdicts.

No brand sponsors a lane, a rating, or a recommendation. If we ever introduce a paid placement, it will be labelled as one — never dressed up as an evidence call.

Why this is structural, not a slogan

A telehealth platform that prescribes and a vendor that ships both earn more when you use more. That incentive doesn’t make them dishonest — but it means their guidance can never be fully neutral, because their revenue moves with your dose.

DoseCraft’s revenue does not move with your dose. We make the same whether you run a protocol, taper one, or decide a compound isn’t for you. That is why we can label a hyped compound “Experimental” without flinching — and why our grading method is published in full.

How we grade evidence Regulatory updates

Not medical advice — educational only. DoseCraft is an information and personal tracking platform. We do not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting any protocol.